Regional Anesthesia for Breast Surgery

Last updated: June 20, 2025
Sponsor: Azienda USL Reggio Emilia - IRCCS
Overall Status: Trial Not Available

Phase

N/A

Condition

Cancer

Breast Cancer

Treatment

PECSII and paravertebral blocks

Clinical Study ID

NCT03941223
Breastblock
  • Ages > 18
  • Female

Study Summary

Patients scheduled for mastecotmy will be randomized to receive either an ultrasound-guided double space paravertebral block or a PECSII + parasternal block. In both groups, blocks will be performed with 20 ml of ropivacaine 0.75%, plus ropivacaine 0.375% 10 ml for parasternal block only.

Postoperative, all patients will receive a morphine PCA. They will follow at 6, 12, 24 months for persistent postoperative surgical pain (PPSP) and cancer recurrence.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients scheduled for radical mastectomy for cancer.

  • age > 18 y-o

  • Written informed consent

Exclusion

Exclusion Criteria:

  • Bilateral surgery

  • Opioids user

  • BMI > 35

  • Postoperative Intensive care

Study Design

Treatment Group(s): 1
Primary Treatment: PECSII and paravertebral blocks
Phase:
Study Start date:
May 29, 2019
Estimated Completion Date:
December 31, 2023

Study Description

Patients scheduled for mastecotmy with or without axillary dissection, will be randomized to receive preoperative either an ultrasound-guided double space paravertebral block or a PECSII + parasternal block. In both groups, blocks will be performed with 20 ml of ropivacaine 0.75%, plus ropivacaine 0.375% 10 ml for parasternal block only.

All the patients also received a general anesthesia induced by propofol and esmeron for endotracheal intubation and desflurane for maintaining.

Sensory block by ice and pinprick test application and maximum spread after 40' from LA injection will be registered.

Postoperative, all patients will receive a morphine PCA, ketorolac 30 mg/12h and paracetamol 1g each 8h.

Morphine consumption will be registered. Patients will follow at 6, 12, 24 months for persistent postoperative surgical pain (PPSP) and cancer recurrence.

Connect with a study center

  • AUSL IRCCS Reggio Emilia

    Reggio Emilia, 42120
    Italy

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.